Motiva® Approval Study:
Successfully Completed – Confirming Cutting-Edge Implant Technology and Maximum Safety
© Stephan Wieland, Düsseldorf Motiva FDA study
Highest product quality and safety for the benefit of our patients
Motiva Implants®: are FDA-approved with an implant-related complication rate of less than 1%.
Since their initial approval in 2010, Motiva Implants® have been implanted in women in over 60 countries, including the United Kingdom, Sweden, Germany, Switzerland, Austria, Japan, Australia, and South Korea. Since their approval by the U.S. Food and Drug Administration (FDA), the implants are now also available in the United States.
Clinical study on product safety
Plastmed is the only study center in Germany out of a total of two study centers in Europe
© Stephan Wieland, Düsseldorf We were the only study center in Germany to conduct a 10-year research study on the FDA approval of Motiva Implants®. The purpose of this study is to determine the safety and efficacy of the test products Motiva Implants® SmoothSilk® Round and Ergonomix® in women undergoing primary breast augmentation. With the successful completion of the study worldwide, no new patients are currently being enrolled in the study.
We will answer your questions in detail during a non-binding initial consultation.
Make an appointment now
© Stephan Wieland, Düsseldorf Dr. med Stephanie Schöpe-Jansen
Assistant physician in further training
Behind every number is a person, behind every procedure is a relationship of trust. In over 15 years and numerous surgeries, we have built up experience that today benefits every single patient.
Interested in a consultation?
We offer non-binding consultations—either in person at our clinic or conveniently online via video. Here’s what you can expect:
- Personal consultation with a specialist physician
- Confidential one-on-one setting
- Detailed discussion of your goals, treatment options, and associated costs
- Initial consultation fee: €50
- Optional: Online video consultation available